Equities

Parenteral Drugs (India) Ltd

Parenteral Drugs (India) Ltd

Actions
Health CareMedical Equipment and Services
  • Price (INR)2.90
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Aug 21 2023.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2022202220212020
ASSETS
Cash And Short Term Investments0.000.571.08
Total Receivables, Net929190
Total Inventory101613
Prepaid expenses------
Other current assets, total569570571
Total current assets671678675
Property, plant & equipment, net2,0543,2183,391
Goodwill, net------
Intangibles, net------
Long term investments242424
Note receivable - long term313028
Other long term assets777169
Total assets4,8425,6795,519
LIABILITIES
Accounts payable987879
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases----5,284
Other current liabilities, total11,91011,3554,694
Total current liabilities12,00811,43310,057
Total long term debt1,0721,0721,072
Total debt1,0721,0726,356
Deferred income tax------
Minority interest1.231.231.23
Other liabilities, total1.051.201.35
Total liabilities13,08312,50811,132
SHAREHOLDERS EQUITY
Common stock298298298
Additional paid-in capital------
Retained earnings (accumulated deficit)(8538)(7127)(5911)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity(8240)(6829)(5613)
Total liabilities & shareholders' equity4,8425,6795,519
Total common shares outstanding303030
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.